openPR Logo
Press release

Oral Transmucosal Drugs Market Outlook 2031: Projected to Reach US$ 27 Billion by 2031, Driven by Rising Demand for Rapid-Acting Therapies

07-02-2025 11:04 AM CET | Health & Medicine

Press release from: Transparency Market Research

Oral Transmucosal Drugs Market

Oral Transmucosal Drugs Market

The global Oral Transmucosal Drugs Market is projected to reach US$ 27 billion by 2031, expanding at a compound annual growth rate (CAGR) of approximately 6% from 2021 to 2031. Oral transmucosal drugs, administered through the mucous membranes of the mouth (e.g., sublingual, buccal), offer rapid absorption and are used for pain management, neurological disorders, and cardiovascular emergencies. The market's growth is driven by increasing demand for fast-acting therapeutics, advancements in drug delivery systems, and rising prevalence of chronic diseases. However, challenges such as high development costs, regulatory complexities, and limited awareness in developing regions persist. This report provides a comprehensive analysis of the market, covering its overview, key drivers, challenges, regional insights, and future opportunities.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82339

Market Overview

The Oral Transmucosal Drugs Market includes formulations like sublingual tablets, buccal films, and sprays for conditions such as pain, opioid dependence, and angina. The market is expected to reach US$ 27 billion by 2031, driven by a CAGR of ~6%. It is segmented by product type (tablets, films, sprays, others), indication (pain management, neurological disorders, cardiovascular, others), distribution channel (hospital pharmacies, retail pharmacies, online), end-user (hospitals, clinics, homecare), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Sublingual tablets dominate due to their widespread use in pain relief, while hospitals lead as end-users.

Key Drivers of Growth

Several factors are propelling the growth of the Oral Transmucosal Drugs Market:

Demand for Rapid-Acting Therapies: The need for quick-onset drugs for acute conditions like pain and cardiovascular emergencies drives market adoption.

Advancements in Drug Delivery: Innovations in buccal and sublingual delivery systems enhance bioavailability and patient compliance, boosting growth.

Rising Chronic Disease Prevalence: Increasing cases of chronic pain, neurological disorders, and cardiovascular diseases fuel demand for transmucosal drugs.

Supportive Regulatory Approvals: Fast-track designations for novel transmucosal formulations by agencies like the FDA and EMA accelerate market entry.

Aging Population: The growing elderly population, prone to conditions requiring rapid treatment, supports market expansion.

Top Companies:

LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Seoul Pharmaceuticals
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
Solvay S.A.
NAL Pharma
IntelGenx Corp.
Izun Pharmaceuticals
Eisai Co., Ltd.
AstraZeneca
Otsuka Pharmaceutical Co., Ltd.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Mylan N.V.
Bristol-Myers Squibb Company

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/oral-transmucosal-drugs-market.html

Challenges and Barriers

Despite its growth potential, the market faces several challenges:

High Development Costs: Formulating transmucosal drugs with optimal absorption and stability is costly, limiting smaller players' participation.

Regulatory Complexities: Stringent regulations for controlled substances (e.g., opioids in transmucosal form) increase compliance costs and delay approvals.

Limited Awareness in Developing Regions: Low awareness of transmucosal delivery in Africa and parts of Asia-Pacific restricts market penetration.

Side Effects Concerns: Potential side effects, such as mucosal irritation or dependency in opioid-based drugs, may reduce patient uptake.

Competition from Alternatives: Injectable and oral drugs with established markets may limit transmucosal drug adoption in some applications.

Regional Insights

The Oral Transmucosal Drugs Market exhibits distinct regional dynamics:

North America: North America dominates, driven by high demand for pain management drugs, advanced healthcare systems, and robust R&D. The U.S. leads due to widespread use of opioid-based transmucosal therapies.

Europe: Europe is a key market, with Germany, France, and the UK benefiting from strong healthcare infrastructure and growing neurological disorder treatments.

Asia-Pacific: Asia-Pacific is expected to witness rapid growth, fueled by rising chronic disease prevalence, improving healthcare access, and investments in China, India, and Japan.

Latin America: Latin America shows moderate growth, with Brazil and Mexico leading due to expanding pharmaceutical markets. Limited awareness slows progress.

Middle East & Africa: This region has the smallest share due to limited healthcare infrastructure. Growth opportunities exist in Gulf countries with rising investments.

Future Opportunities

The Oral Transmucosal Drugs Market offers several avenues for growth and innovation:

Novel Delivery Systems: Developing advanced buccal films and sprays with enhanced bioavailability could drive market demand.

Expansion in Emerging Markets: Increasing healthcare investments in Asia-Pacific and Latin America present opportunities for affordable transmucosal drugs.

Non-Opioid Formulations: Research into non-opioid transmucosal drugs for pain management could address safety concerns and boost adoption.

Digital Health Integration: Telemedicine and patient monitoring tools could improve adherence to transmucosal therapies, enhancing market reach.

Partnerships with Pharma Companies: Collaborations can streamline development and distribution of transmucosal drugs, supporting market growth.

Browse More Trending Research Reports:

Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html

Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html

Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html

Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oral Transmucosal Drugs Market Outlook 2031: Projected to Reach US$ 27 Billion by 2031, Driven by Rising Demand for Rapid-Acting Therapies here

News-ID: 4089362 • Views:

More Releases from Transparency Market Research

Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Rising Ocular Disease Burden and Advancements in Eye Surgery
Global Ophthalmic Sutures Market to Reach USD 1.3 Billion by 2034, Driven by Ris …
The global Ophthalmic Sutures Market is experiencing significant momentum as demand surges for improved ophthalmic surgical outcomes amid increasing incidences of ocular disorders worldwide. According to the latest industry assessment, the market, valued at US$ 629.0 million in 2023, is projected to expand at a CAGR of 6.5% between 2024 and 2034, ultimately reaching US$ 1.3 billion by 2034. This comprehensive press release provides an in-depth examination of market size, trends,
Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising Ophthalmic Disease Burden and Advances in Diagnostic Imaging
Global Ophthalmology PACS Market to Reach USD 359.8 Mn by 2034, Driven by Rising …
The global Ophthalmology PACS (Picture Archiving and Communication System) Market is poised for strong expansion over the next decade as the industry continues transitioning toward digital, AI-enabled ophthalmic imaging management solutions. According to recent market assessments, the global Ophthalmology PACS market valued at US$ 167.8 Mn in 2023 is projected to grow at a CAGR of 7.3% from 2024 to 2034, ultimately reaching US$ 359.8 Mn by the end of
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 2031 Amid Rising Incidence of Cataracts and Glaucoma
Global Ophthalmology Surgical Devices Market Set to Reach USD 12.1 Billion by 20 …
The global Ophthalmology Surgical Devices Market is poised for steady expansion, driven by rising demand for advanced surgical systems, increasing prevalence of cataracts and glaucoma, and accelerating adoption of minimally invasive techniques. The market was valued at US$ 8.1 billion in 2022 and is projected to reach US$ 12.1 billion by 2031, expanding at a CAGR of 4.7% from 2023 to 2031. Unlock crucial data and key findings from our Report
Global Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034, Driven by Rising Addiction Rates and Government Initiatives
Global Opioid Use Disorders Market to Reach US$ 8.8 Billion by 2034, Driven by R …
The global Opioid Use Disorders (OUD) Market is set for strong expansion over the next decade, rising from US$ 3.2 billion in 2023 to an estimated US$ 8.8 billion by 2034, according to the latest industry assessment. The market is projected to grow at a CAGR of 9.9% from 2024 to 2034, supported by increasing government funding, rising public awareness, and the escalating prevalence of opioid addiction across all major

All 5 Releases


More Releases for Oral

Oral Care Oral Hygiene Market Size, Share | Forecast 2032
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Oral Care Oral Hygiene Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key
Oral Care Oral Hygiene Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Oral Care Oral Hygiene Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion. The oral care and oral hygiene market encompasses a wide array of products and services designed to maintain and improve oral health. This
Enhancing Oral Health: The Growing Oral Irrigator Market
The oral irrigator market stands at the forefront of the dental care industry, boasting remarkable growth prospects. In 2023, it was valued at USD 919.1 million, and it is projected to maintain this momentum with a compound annual growth rate (CAGR) of 3.5% expected during the forecast period from 2024 to 2032. By 2032, it is anticipated to reach a staggering market valuation of USD 1252.7 million. This remarkable ascent
Oral Care & Oral Hygiene Market to see Huge Growth by 2028
This comprehensive report thoroughly assesses various regions, estimating the volume of the global Oral Care & Oral Hygiene market within each region during the projected timeframe. The report is meticulously crafted and includes valuable information on the current market status, historical data, and projected outlook. Furthermore, it presents a detailed market analysis, segmenting it based on regions, types, and applications. The report closely monitors key trends that play a crucial
Oral Care/Oral Hygiene Market Size, Share, Growth Report 2030
Latest Updated Report 2023, The Global Oral Care/Oral Hygiene Market to Growing A CAGR of % during forecast period of 2023-2030. The Market is segmented by Global Oral Care/Oral Hygiene Market Breakdown by Application (Consumer use, Clinic, Hospital) by Type (Toothpastes, Toothbrushes And Accessories, Mouthwashes/Rinses, Dental Accessories/Ancillaries, Denture Products, Dental Prosthesis Cleaning Solutions) and by Geography (North America, South America, Europe, Asia Pacific, MEA). The Oral Care/Oral Hygiene Market 2023 Report
Oral Care/Oral Hygiene Market - Current Impact to Make Big Changes
A new market study is released on Global Oral Care/Oral Hygiene Market with data Tables for historical and forecast years represented with Chats & Graphs spread through 119 Pages with easy to understand detailed analysis. The study highlights detailed assessment of the Market and display market sizing trend by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry validated market development data. The research study provides